SelfDecode

📍 United States🗓 Founded 2016👥 59 employees💰 Last funded Oct 2021
Biotechnology Research🌐 selfdecode.com
Website LinkedIn
Revolutionizing the healthcare industry by providing an integrated AI platform that provides personalized health recommendations based on a combination of your DNA, labs, and environmental factors. SelfDecode is the only company in the world providing ancestry-adjusted Polygenic Risk Scoring directly to the consumer. Through our R&D division (OmicsEdge), we are making precision health affordable to all by empowering organizations to easily build precision health products using our bioinformatics infrastructure. Our core abilities include ancestry-adjusted Polygenic Risk Scoring, which we license to other organizations.
2
Total investors
0
Early stage
2
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in SelfDecode?
SelfDecode has 2 investors on record on gritt.io, 2 mid-stage.
When did SelfDecode last raise funding?
The most recent investment in SelfDecode recorded on gritt.io was in October 2021.
When was SelfDecode founded?
SelfDecode was founded in 2016.
What industry is SelfDecode in?
SelfDecode operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is SelfDecode based?
SelfDecode is headquartered in United States.